Sign in Subscribe
Cancer

PEGylated Liposomes Enhance Cancer Therapy Efficacy in Hypoxic Tumors

Strategic Insights

— 1 min read

A team of researchers from Guizhou University has designed and synthesized a novel nanoplatform that combines photodynamic therapy (PDT) with photothermal therapy (PTT) to overcome cancer treatment resistance in hypoxic tumors. The study, published in the journal Lasers in Medical Science, demonstrates the efficacy of the PEGylated liposomes in enhancing the therapeutic outcomes of PDT for cancer treatment.

Key Takeaways:

  • The researchers designed PEGylated liposomes (ICG/MnO2-HFn-mPEG-DSPE-Lip) that incorporate MnO as a hypoxia-modulating agent, ICG as a photosensitizer, and H-chain ferritin as an oxygen carrier.
  • The liposomes have a high drug loading capacity, good biocompatibility, and long-term stability, making them suitable for cancer treatment.
  • Under tumor-simulated conditions, the singlet oxygen quantum yield (PH) was significantly improved, increasing from 0.210 for free ICG to 0.507.
  • The liposomes demonstrated remarkable phototoxic effects on A549 cells, with 90.5% cell death under combined PDT/PTT conditions compared to 15% for free ICG.
  • The nanoplatform proposes a novel strategy to overcome hypoxia-induced PDT resistance, potentially leading to enhanced efficacy in cancer treatment.
  • The study's findings provide important insights for the development of next-generation therapeutic systems targeting tumor hypoxia.

Statistics:

  • 90.5%: cell death rate of A549 cells under combined PDT/PTT with PEGylated liposomes
  • 15%: cell death rate of A549 cells under PDT with free ICG
  • 0.210: singlet oxygen quantum yield (PH) for free ICG
  • 0.507: singlet oxygen quantum yield (PH) for PEGylated liposomes under tumor-simulated conditions
  • 40.1: volume number of the journal Lasers in Medical Science where the study was published
  • 1: issue number of the journal where the study was published
  • 243: page number where the study was published
  • 2025: year of publication for the study

Sources:

  • ICG/MnO2-HFn-mPEG-DSPE-Lip enhances the anticancer activity of ICG phototherapy. Lasers in Medical Science, 2025;40(1):243.
  • NewsRx. Guizhou University Reports Findings in Cancer Gene Therapy (ICG/MnO2-HFn-mPEG-DSPE-Lip enhances the anticancer activity of ICG phototherapy). Chemicals & Chemistry. June 13, 2025; p 1414.

Read more